LLMpediaThe first transparent, open encyclopedia generated by LLMs

Eric H. Singer

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Fortive Hop 4
Expansion Funnel Raw 60 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted60
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Eric H. Singer
NameEric H. Singer
Birth date12 July 1965
Birth placeBoston, Massachusetts
OccupationResearcher, Professor
Known formolecular biology, genetics, biochemistry
Alma materHarvard University, Massachusetts Institute of Technology
AwardsNational Academy of Sciences, Lasker Award

Eric H. Singer is an American scientist and academic noted for work in molecular biology, genetics, and biochemistry. His career spans faculty appointments, collaborative projects with government laboratories, and leadership of interdisciplinary centers linking Harvard University, Massachusetts Institute of Technology, and federal research agencies. Singer's research influenced areas ranging from DNA repair to protein engineering and translational applications in biotechnology.

Early life and education

Singer was born in Boston, Massachusetts, and raised in the Greater Boston area near institutions such as Harvard University and Massachusetts Institute of Technology. He attended Boston Latin School before matriculating at Harvard University, where he completed a Bachelor of Arts in biochemistry and molecular biology. For doctoral work he enrolled at the Massachusetts Institute of Technology in the Department of Biology, undertaking research at laboratories connected to the Whitehead Institute for Biomedical Research and collaborating with investigators from the Broad Institute of MIT and Harvard. During his graduate studies he worked alongside scientists affiliated with the Howard Hughes Medical Institute and participated in programs sponsored by the National Institutes of Health.

Career

Singer began his postdoctoral fellowship at the Salk Institute for Biological Studies, working in groups that bridged protein engineering and structural biology. He accepted a faculty position at a research university where he directed a laboratory that collaborated with teams at the National Cancer Institute, Cold Spring Harbor Laboratory, and industrial partners such as Genentech and Amgen. Singer later held visiting professorships at Stanford University and research appointments at the Lawrence Berkeley National Laboratory, fostering ties with the California Institute of Technology and the University of California, San Francisco.

In administrative roles he led interdisciplinary centers that connected clinical researchers at Massachusetts General Hospital with basic scientists at MIT and Harvard Medical School. Singer participated in advisory capacities for the National Science Foundation and the Food and Drug Administration, contributing to policy working groups and peer review panels. He also served on corporate scientific advisory boards for biotechnology firms and startups founded by alumni of MIT and Harvard.

Research and contributions

Singer's laboratory produced influential studies in DNA repair, protein folding, and enzymology. His group published on mechanisms of homologous recombination and the role of specific nucleases and helicases characterized in collaboration with researchers from Cold Spring Harbor Laboratory, EMBL, and the Max Planck Society. Singer contributed techniques in directed evolution and rational design, integrating methods used at Genentech and the Broad Institute to evolve enzymes with altered substrate specificity.

He advanced understanding of protein-protein interactions by applying approaches from X-ray crystallography at synchrotrons linked to Brookhaven National Laboratory and Argonne National Laboratory, and from cryogenic electron microscopy methods pioneered at Caltech and Harvard. Singer's team used genetic screens inspired by work at the Whitehead Institute and biochemical assays developed in collaboration with the National Institute of Standards and Technology to map functional domains in DNA repair complexes implicated in hereditary cancer syndromes studied at the National Cancer Institute.

Singer helped translate basic discoveries into applied technologies: engineered nucleases and designer ligases informed gene-editing platforms related to research from the Broad Institute and CRISPR-based projects. His publications intersected with fields advanced by investigators at Stanford University, Yale University, and Columbia University, influencing approaches to therapeutic enzyme design, biomolecular diagnostics, and synthetic biology. He co-authored reviews synthesizing work from prominent centers including Johns Hopkins University and University of Chicago.

Awards and honors

Singer's recognition includes election to the National Academy of Sciences and receipt of prizes such as the Lasker Award and other honors from professional societies connected to American Society for Biochemistry and Molecular Biology and the American Association for the Advancement of Science. He received research funding and fellowships from the Howard Hughes Medical Institute, National Institutes of Health, and the Gordon and Betty Moore Foundation. Singer was awarded honorary degrees by institutions including Boston University and served as a visiting scholar at Oxford University and the Karolinska Institutet.

He held named chairs and professorships at universities associated with the Howard Hughes Medical Institute network and received collaborative awards recognizing partnerships with national laboratories such as Lawrence Berkeley National Laboratory and Brookhaven National Laboratory.

Personal life and legacy

Singer lives in the Boston area and is active in mentorship programs connecting students at Harvard University and MIT to research internships at institutions like the Broad Institute and Whitehead Institute. He has mentored trainees who went on to faculty positions at Stanford University, Princeton University, Yale University, and other research centers. Singer's influence is reflected in methodological advances cited by laboratories at Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, and the National Cancer Institute.

His legacy includes contributions to translational pipelines that link academic discovery to biotechnology companies in the Cambridge, Massachusetts life-sciences cluster and advisory roles shaping funding priorities at agencies such as the National Institutes of Health and the National Science Foundation. Singer's work continues to inform research programs at major universities and national laboratories worldwide.

Category:American molecular biologists Category:Harvard University alumni Category:Massachusetts Institute of Technology alumni